Patton Albertson Miller Group, LLC
- SEC CIK
- 0001511037
- Latest filing
- Jul 22, 2026
The latest 13F from Patton Albertson Miller Group, LLC covers Q2 2026 (filed Jul 22, 2026): 213 long positions worth $1.00B. The top 10 holdings make up 33.1% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 5.3%. Livermore has 24 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 5
- Est. +$13.8M
- Added
- 46
- Est. +$22.2M
- Reduced
- 122
- Est. −$26.6M
- Sold out
- 4
- Est. −$935.3K
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
- BlackRock ETF Trust09290C764+$12.8MNew
- J P Morgan Exchange Traded F46641Q852+$6.62MAdded
- MUMicron Technology Inc
- iShares S&P 500 Growth ETF464287309+$2.10MAdded
- Global X FDS37960A529+$1.90MAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $1.00B
- +$162.6M (+19.3%) vs. prior quarter
- Positions
- 213
- +1 vs. prior quarter
- Top 10 concentration
- 33.1%
- Top 10 as share of value
- Turnover
- 3.0%
- Q2 2026, one quarter
- Average holding period
- 18.1 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $1.00B (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 22, 2026 | 213 | $1.00B | NVDAAAPLBlackRock ETF Trust | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 21, 2026 | 212 | $842.3M | NVDAAAPLiShares Core S&P 500 ETF | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 3, 2026 | 214 | $850.3M | NVDAAAPLiShares Core S&P 500 ETF | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 3, 2025 | 207 | $828.2M | NVDAAAPLiShares Core S&P 500 ETF | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 17, 2025 | 213 | $759.6M | NVDAiShares Core S&P 500 ETFAAPL | vs. Q1 2025 | SEC |
| Q1 2025 | May 22, 2025Amended | 214 | $673.4M | NVDAiShares Core S&P 500 ETFAAPL | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 21, 2025 | 220 | $747.5M | NVDAAAPLiShares Tr | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 13, 2024 | 218 | $734.2M | NVDAAAPLiShares Tr | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 2, 2024 | 206 | $703.7M | NVDAAAPLiShares Tr | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 24, 2024 | 202 | $667.5M | NVDAiShares TrAAPL | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024Amended | 201 | $599.4M | iShares TrAAPLNVDA | vs. Q3 2023 | SEC |
| Q3 2023 | Oct 24, 2023 | 204 | $509.8M | iShares TrAAPLNVDA | vs. Q2 2023 | SEC |
| Q2 2023 | Jul 13, 2023 | 205 | $517.6M | iShares TrAAPLNVDA | vs. Q1 2023 | SEC |
| Q1 2023 | Apr 21, 2023 | 215 | $545.9M | iShares TrAAPLiShares Tr | vs. Q4 2022 | SEC |
| Q4 2022 | Jan 23, 2023 | 216 | $544.6M | iShares TriShares TrAAPL | vs. Q3 2022 | SEC |
| Q3 2022 | Oct 13, 2022 | 211 | $465.2M | iShares TrAAPLiShares Core High Dividend ETF | vs. Q2 2022 | SEC |
| Q2 2022 | Jul 22, 2022 | 224 | $489.5M | iShares TrAAPLKO | vs. Q1 2022 | SEC |
| Q1 2022 | May 2, 2022 | 243 | $581.8M | iShares TrAAPLNVDA | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 11, 2022 | 250 | $618.2M | iShares TrAAPLPIMCO Active Bond Exchange-Traded Fund | vs. Q3 2021 | SEC |
| Q3 2021 | Oct 27, 2021 | 238 | $523.2M | iShares TrAAPLiShares U.S. Medical Devices ETF | vs. Q2 2021 | SEC |
| Q2 2021 | Jul 29, 2021 | 201 | $439.2M | iShares TrAAPLiShares U.S. Medical Devices ETF | vs. Q1 2021 | SEC |
| Q1 2021 | Apr 21, 2021 | 198 | $413.6M | iShares TrAAPLiShares Tr | – | SEC |